|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
1998-9-9
|
|
pubmed:abstractText |
The generalized type of social phobia (social anxiety disorder) is a severe and often disabling form of social anxiety that affects approximately 5% of the general population. Earlier research has shown monoamine oxidase inhibitors or benzodiazepines to be effective in treating this condition, but neither has achieved widespread use.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0098-7484
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
26
|
|
pubmed:volume |
280
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
708-13
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9728642-Adult,
pubmed-meshheading:9728642-Aged,
pubmed-meshheading:9728642-Antidepressive Agents, Second-Generation,
pubmed-meshheading:9728642-Double-Blind Method,
pubmed-meshheading:9728642-Female,
pubmed-meshheading:9728642-Humans,
pubmed-meshheading:9728642-Logistic Models,
pubmed-meshheading:9728642-Male,
pubmed-meshheading:9728642-Middle Aged,
pubmed-meshheading:9728642-Multicenter Studies as Topic,
pubmed-meshheading:9728642-Paroxetine,
pubmed-meshheading:9728642-Personality Tests,
pubmed-meshheading:9728642-Phobic Disorders,
pubmed-meshheading:9728642-Serotonin Uptake Inhibitors
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial.
|
|
pubmed:affiliation |
Department of Psychiatry, University of California at San Diego, La Jolla 92093-0985, USA. mstein@ucsd.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
